Skip to content

Exploring the Experiences and Outcomes of a Summer Intensive Therapy Program- Mixed Methods Study

Exploring the Experiences and Outcomes of a Summer Intensive Therapy Program- Mixed Methods Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05443763
Enrollment
15
Registered
2022-07-05
Start date
2022-05-23
Completion date
2022-09-01
Last updated
2023-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Children With Neurodevelopmental Disorders

Brief summary

The purpose of this study is to assess the effectiveness of an interdisciplinary intensive therapy program for ambulatory and non-ambulatory children with neurodevelopmental disorders across the ICF and to explore caregiver experiences and perspectives of the program.

Detailed description

The purpose of this study is to assess the effectiveness of an interdisciplinary intensive therapy program for ambulatory and non-ambulatory children with neurodevelopmental disorders across the ICF and to explore caregiver experiences and perspectives of the program. Research questions include: 1.) What are the effects of an intensive program on postural control and functional mobility for children with neurodevelopmental disorders? 2.) What are the effects of an intensive therapy program on dual tasking for children with neurodevelopmental disorders? 3.) What are the perceptions of caregivers of a multidisciplinary intensive therapy program for their children with neurodevelopmental disorders? Data will be gathered before and after the intensive program as part of usual care and ambulatory children will be further assessed in the motion analysis lab. Caregivers will complete a questionnaire about satisfaction with services and also a 4 question open-ended question survey about their experience with intensive therapy.

Interventions

OTHERAn interdisciplinary intensive therapy program

Children will receive physical, occupation, and/or speech therapy 1-3 hours/day each for 4-5 days/week x 4 weeks.

Sponsors

University of Missouri-Columbia
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Cohort study of children receiving intensive therapy and their caregivers

Eligibility

Sex/Gender
ALL
Age
2 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

* Children receiving therapy through Children's Therapy Center's Tiger Intensive Program and their caregivers from May 23, 2022, to Aug 19, 2022.

Exclusion criteria

* none

Design outcomes

Primary

MeasureTime frameDescription
Instrumented Gait Analysisbefore intensive therapy episode of care, approximately 4 weeks3D gait analysis in gait lab
Center of pressure measureafter intensive therapy episode of care, approximately 4 weeksCOP measure during balance task
Measures of processes of care (MOPC)after intensive therapy episode of care, an average of 4 weeksQuestionnaire to assess satisfaction with therapy services
Timed up and gobefore intensive therapy episode of care, an average of 4 weeksTUG assessment--timed assessment including standing from a chair, walking a distance and returning to the chair
Modified Clinical Test of Sensory Integration and Balanceafter intensive therapy episode of care, an average of 4 weeksmCISIB--balance test in 4 conditions
Pediatric Balance Scalebefore intensive therapy episode of care, an average of 4 weeksPBS-balance test
Functional Gait Assessment (FGA)before intensive therapy episode of care, an average of 4 weeksAssesses functional gait performance
Segmental Assessment of Trunk Control (SATCo)before intensive therapy episode of care, an average of 4 weeksAssessment of trunk control
Surveyafter intensive therapy episode of care, an average of 4 weeks4 open-ended questions about caregiver/child experience with intensive therapy program

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026